¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

ÀÎõ°©»ó¼±ÇÑÀÇ¿ø ÇÑÀÇ¿ø ¼­µÎ¸£¼¼¿ä

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 
#¼Ûµµ°©»ó¼±ÇÑÀÇ¿ø, #¼Ûµµ°©»ó¼±ÇÑÀÇ¿øÇÑÀÇ¿ø, #°©»ó¼º±â´ÉÀúÇÏÁõ, #¼Ûµµ°©»ó¼º±â´ÉÀúÇÏÁõ, #°©»ó¼±ÇÑÀÇ¿øÇÑÀÇ¿ø, #°©»ó¼º±â´ÉÀúÇÏÁõÇÑÀÇ¿ø, #¼Ûµµ°©»ó¼º±â´ÉÀúÇÏÁõ, #ºÎõ°©»ó¼±ÇÑÀÇ¿ø ¼Ûµµ°©»ó¼±ÇÑÀÇ¿ø,,¼Ûµµ°©»ó¼±ÇÑÀÇ¿øÇÑÀÇ¿ø,,°©»ó¼º±â´ÉÀúÇÏÁõ,,¼Ûµµ°©»ó¼º±â´ÉÀúÇÏÁõ,,°©»ó¼±ÇÑÀÇ¿øÇÑÀÇ¿ø,,°©»ó¼º±â´ÉÀúÇÏÁõÇÑÀÇ¿ø,,¼Ûµµ°©»ó¼º±â´ÉÀúÇÏÁõ,,ºÎõ°©»ó¼±ÇÑÀÇ¿ø ¾È³çÇϼ¼¿ä. ¼Ûµµ°©»ó¼±ÇÑÀÇ¿ø ºÎõ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä ¼Ûµµ°©»ó¼±ÇÑÀÇ¿ø ºÎõ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ¼ÛµµÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â°©»ó¼º±â´ÉÀúÇÏÁõ, °©»ó¼±ÇÑÀÇ¿ø, °©»ó¼±È¤, °©»ó¼±Áõ»ó, °©»ó¼±¿ä¿Àµå, °©»ó¼±±â´ÉÇ×ÁøÁõ, °©»ó¼±Å¬¸®´Ð, °©»ó¼±Ä¡·á, °©»ó¼±±â´ÉÀúÇÏÁõÇÑÀÇ¿ø, °©»ó¼±, °©»ó¼±Ç×ÁøÁõ, °©»ó¼±µÎÅë, ¸ñ°©»ó¼±, °©»ó¼±¿ä¿Àµå, °©»ó¼º±â´ÉÀúÇÏÁõ, °©»ó¼±Ã¼ÁßÁõ°¡, °©»ó¼±±â´ÉÀúÇÏÁõÀÓ½Å, °©»ó¼±ºÎÀ½, °©»ó¼±±â´ÉÀúÇÏÁõÀÓ½Å, °©»ó¼±±â´ÉÇ×ÁøÁõÇÑÀÇ¿ø, °©»ó¼±Ä¡·á, °©»ó»ùÀúÇÏÁõ, °©»ó¼±°áÀý, °©»ó¼±È¤Áõ»ó, °©»ó¼±Ã¼ÁßÁõ°¡µî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó Àδ밭ȭ, üÁßÁ¶Àý¿µ¾ç±³À°ÆÐÅ°Áö, ôÃß±â±âµµÀÎ, ¸¶»çÁö, °üÀýôÃߺÀ¾àħ¿ä¹ý, ¾Æ·Î¸¶Å׶óÇÇ, ÃÊÀ½ÆĽɺο­Ä¡·á, ±Ý¿¬Ä§, ÇѹæÀçÈ°, ÀåħÀü±âÀڱؼú, °ñµµ¹ý°Ë»ç, °üÀýº¸È£´ë, ºñ°­·¹ÀÌÀú, °æÇÇÀû¿Ü¼±Á¶»ç¿ä¹ý, sonostim, ÀÚÇϰžàħ, Ư¼öÃß³ª, ¾óÀ½ÆÑ, µµÀοä¹ý, ¼ÒÇÕÇâ¿ø, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù ¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀÌ¸ç °æ³² °í¼º±º ¿µÇö¸é, °æ±â ¼º³²½Ã Áß¿ø±¸ ÇÏ´ë¿øµ¿, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ ´ë¿Üµ¿, °æºÏ ±èõ½Ã ÀÀ¸íµ¿, Ãæ³² È«¼º±º Àå°î¸é, °æ±â µ¿µÎõ½Ã ±¤¾Ïµ¿, °æ³² °í¼º±º ¿µ¿À¸é, ÃæºÏ û¿ø±º ¿À¼ÛÀ¾, ÀüºÏ ÀÍ»ê½Ã ¿©»ê¸é, °æ³² ÇԾȱº Ä¥ºÏ¸é, Ãæ³² ´çÁø½Ã ä¿îµ¿, ¼¼Á¾ ÇѼֵ¿, °æ±â ¾È¼º½Ã »ç°îµ¿, ºÎ»ê ¼­±¸ ¼­´ë½Åµ¿1°¡, ºÎ»ê Áß±¸ ³²Æ÷µ¿2°¡, ºÎ»ê Áß±¸ º¸¼öµ¿1°¡, ÀüºÏ ±èÁ¦½Ã º¹Á×µ¿, ºÎ»ê °­¼­±¸ °­µ¿µ¿, ÀüºÏ ÀüÁֽà ¿Ï»ê±¸ È¿ÀÚµ¿3°¡, Ãæ³² °øÁֽà ¿ù¹Ìµ¿, °æ±â ¾È¾ç½Ã ¸¸¾È±¸ ¾È¾ç9µ¿, °æ±â ±ºÆ÷½Ã »êº»µ¿, ºÎ»ê »çÇϱ¸ ½ÅÆòµ¿, Àü³² ¿©¼ö½Ã µ¹»êÀ¾, °æºÏ ¿µÃµ½Ã ±ÝÈ£À¾, ¿ï»ê ºÏ±¸ È¿¹®µ¿, ÀÎõ ³²µ¿±¸ ¼­Ã¢µ¿, ÃæºÏ ¿µµ¿±º ¸Å°î¸é, ¼¼Á¾ ¹Ý°îµ¿, ¿ï»ê ³²±¸ ¼º¾Ïµ¿, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù ¼Ûµµ°©»ó¼±ÇÑÀÇ¿øÄ¡·á ãÀ¸½Ã´Â °è¾ç±¸, ±¸¿ùµ¿, ÆÈź¸é, ÀÎõ, µ¿Ãᵿ, ¹è°ð½Åµµ½Ã, µµÈ­µ¿, ºñºÀ¸é, û¶ó, »óµ¿, ¿¬Èñµ¿, Á־ȵ¿, °è»êµ¿, ¸¶µµ¸é, °¡Á¤µ¿, ³²¾çÀ¾, µ¿±¸, µ¿ÀÎõ, ¼Ûµµ, ¼Ûµµ½Åµµ½Ã, ¼Û¿ùµ¿, µµ¸²µ¿, ½ÃÈï, ¹è°ð, °ü±³µ¿, ûÇе¿, ¼Û»ê¸é, ¿î¼­µ¿, ½ÃÈ­, °£¼®µ¿, ¿µÁ¾Çϴõµ½Ã, °¡Áµ¿, ´ëºÎµµ, ÀÎõ³íÇöµ¿, ¼Ò·¡Æ÷±¸ µî ¼Ûµµ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿ø¼ÛµµÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù. ´õ »ìÆ캸±â 1. CATZ B, RUSSELL S. Myxedema, shock and coma. Seven survival cases. Arch Intern Med 1961; 108:407. 2. Sawka AM, Gerstein HC, Marriott MJ, et al. Does a combination regimen of thyroxine (T4) and 3,5,3'-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 2003; 88:4551. 3. Saravanan P, Simmons DJ, Greenwood R, et al. Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial. J Clin Endocrinol Metab 2005; 90:805. 4. Aronson R, Offman HJ, Joffe RT, Naylor CD. Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Arch Gen Psychiatry 1996; 53:842. 5. Duntas LH. Selenium and the thyroid: a close-knit connection. J Clin Endocrinol Metab 2010; 95:5180. 6. Pollock MA, Sturrock A, Marshall K, et al. Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial. BMJ 2001; 323:891. 7. Hennemann G, Docter R, Visser TJ, et al. Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: proof of principle. Thyroid 2004; 14:271. 8. Blakesley V, Awni W, Locke C, et al. Are bioequivalence studies of levothyroxine sodium formulations in euthyroid volunteers reliable? Thyroid 2004; 14:191.
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎõ°©»ó¼±ÇÑÀÇ¿ø ÇÑÀÇ¿ø ¼­µÎ¸£¼¼¿ä""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ½ÃÈïÇÑÀÇ¿øÀßÇϴ°÷ Ä¡·á Ãʱ⿡ ÀâÀÚ
´ÙÀ½±Û ¼Ûµµ´ÙÀ̾îÆ® ÇÑÀÇ¿ø¿¡¼­
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
872 ½ÅÃÌ´ÙÀ̾îÆ®ÇÑ¾à °Ç°­ÇÏ°Ô °ü¸®¸¦ ÇÏ°í ¿øÇÏ´Â ¸öÀ» ¸¸µé±â 3 1,121 2022-01-19
871 ¿ï»ê´ÙÀ̾îÆ®ÇÑÀÇ¿ø ÀÚ¿¬°úÇÑÀÇ¿ø¿¡¼­ ¼ö¿ùÇÏ°Ô Ã¼Áß °¨·® 1 1,231 2022-01-19
870 ºÐ´ç´ÙÀ̾îÆ®ÇÑÀÇ¿ø 1 1,405 2022-01-19
869 õ¾È´ÙÀ̾îÆ®ÇÑÀÇ¿ø ¿ÃÇØ »ì »©±â ¼º°øÇÏ°í ½ÍÀ¸¸é ÀÚ¿¬°úÇÑÀÇ¿ø¿¡¼­! 1 1,168 2022-01-19
868 ÀÏ»ê´ÙÀ̾îÆ®ÇÑÀÇ¿ø °èȹÀûÀÌ°í ¼øÁ¶·Î¿î üÁß °¨·® 1 828 2022-01-19
867 ÀºÆò¿¬½Å³»´ÙÀ̾îÆ®ÇÑÀÇ¿ø¿¡¼­ °Ç°­ÇÏ°Ô °ü¸®¸¦ ÇØ¿ä 1 820 2022-01-18
866 ¼ö¿ø´ÙÀ̾îÆ®ÇÑÀÇ¿ø ³ª¿¡°Ô ¸Â´Â ¹æ½ÄÀ¸·Î ¿Ã¹Ù¸£°Ô 1 860 2022-01-18
865 ûÁÖ´ÙÀ̾îÆ®ÇÑÀÇ¿ø °Ç°­ÇÏ°Ô °ü¸®¸¦ ÇغÁ¿ä 0 607 2022-01-18
864 µ¿Åº´ÙÀ̾îÆ®ÇÑÀÇ¿ø ¸¸Á·°¨ ³ôÀº °ü¸® 2 789 2022-01-18
863 ÇØ¿î´ë´ÙÀ̾îÆ®ÇÑÀÇ¿ø ÀÚ¿¬°úÇÑÀÇ¿ø¿¡¼­ ÀÌ»Û ¸öÀ» ¸¸µé¾î¿ä 1 636 2022-01-18
862 ÆòÃÌ´ÙÀ̾îÆ®ÇÑÀÇ¿ø ÀÚ¿¬°úÇÑÀÇ¿ø¿¡¼­ üÁú¿¡ ¸Â°Ô ÁøÇàÇϼ¼¿ä 2 602 2022-01-18
861 ¸ñµ¿´ÙÀ̾îÆ®ÇÑÀÇ¿ø °Ç°­ÇÑ Ã¼Áß °ü¸® ¹æ¹ýÀ» ¼±Åà 1 655 2022-01-18
860 ¸íµ¿´ÙÀ̾îÆ®ÇÑÀÇ¿ø °Ç°­ÇÑ Ã¼Áß °ü¸® ÇÒ ¼ö ÀÖ¾î¿ä 1 537 2022-01-18
859 ¼­¸é´ÙÀ̾îÆ®ÇÑÀÇ¿ø ÀÚ¿¬°úÇÑÀÇ¿ø°ú ÇÔ²² °ü¸®¸¦ ÇغÁ¿ä 1 802 2022-01-18
858 ±¤ÁÖ´ÙÀ̾îÆ®ÇÑÀÇ¿ø ÀÚ¿¬°úÇÑÀÇ¿ø¿¡¼­ È¿À²ÀûÀ¸·Î üÁß °ü¸® ÇØ º¸¼¼¿ä 2 842 2022-01-18
857 °­³²´ÙÀ̾îÆ®ÇÑÀÇ¿ø °Ç°­°ú üÁß °ü¸® ¸ðµÎ ÀâÀ» ¼ö ÀÖ¾î¿ä 2 485 2022-01-18
856 ¼öÇÑÀÇ¿ø °Ü¿ï¹æÇÐ ¿©µå¸§°ü¸® ÇÒÀÎ À̺¥Æ® 0 1,132 2021-11-29
855 Àϻ긮»ùÇÑÀÇ¿ø 11¿ùÀ̺¥Æ®¼Ò½Ä 0 828 2021-10-26
854 Àá½Ç»õ³»¿ª ÇÑÀÇ¿ø ¸¶À½¸ð¾ÆÇÑÀÇ¿ø 10¿ùÁø·á¾È³» 0 648 2021-09-29
853 ¸¶»ê´ÙÀ̾îÆ® °æÈñÀÚ¿¬ÇÑÀÇ¿ø 10¿ùÀ̺¥Æ® 0 1,061 2021-09-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷